Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
New user? Click here to register.Have you forgotten your password?
  1. Home
  2. CRIS
  3. Publication
  4. Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial
Details

Colchicine and the combination of rivaroxaban and aspirin in patients hospitalised with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

Journal
The Lancet Respiratory Medicine
ISSN
2213-2600
Date Issued
2022-12
Author(s)
John W Eikelboom
Sanjit S Jolly
Emilie P Belley-Cote
Richard P Whitlock
Sumathy Rangarajan
Lizhen Xu
Laura Heenan
Shrikant I Bangdiwala
Maria Luz Diaz
Rafael Diaz
Afzalhussein Yusufali
Sanjib Kumar Sharma
Wadea M Tarhuni
Mohamed Hassany
Alvaro Avezum
William Harper
Sean Wasserman
Aysha Almas
Oxana Drapkina
FELIX GALLEGOS, CAMILO EDGAR VINICIO  
Facultad de Ciencias de la Salud Eugenio Espejo  
Renato D Lopes
Otavio Berwanger
Patricio Lopez-Jaramillo
Sonia S Anand
Jackie Bosch
Shurjeel Choudhri
Michael E Farkouh
Mark Loeb
Salim Yusuf
DOI
10.1016/S2213-2600(22)00298-3
URL
https://cris.ute.edu.ec/handle/123456789/454

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback

Hosting & Support by

Built with DSpace-CRIS software - Extension maintained and optimized by 4science

Repository logo COAR Notify